RO6806127

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO6806127, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of RO6806127 in Healthy Male Volunteers [Phase 1]